Virginie Blanvillain Rivera
Company: MicroSintesis
Job title: Clinical Research Manager
Seminars:
Understanding Microbiome Therapies, a New Approach to Solving Dysbiosis-Related Challenges as an Alternative to Antibiotic Treatment 1:30 pm
day: Day One
Understanding Microbiome Therapies, a New Approach to Solving Dysbiosis-Related Challenges as an Alternative to Antibiotic Treatment 1:30 pm
•Proteobiotics contain targeted groups of biopeptides that have the ability to disrupt quorum sensing and virulence gene expression of pathogens such as E.coli and Clostridium perfringens • In-water administration of proteobiotics to broilers challenged on Clostridium perfringens showed a significant reduction in necroticrelated mortality from 24.7% to 13.5% • In-water administration of proteobiotics to piglets…Read more
day: Day One